Immco Diagnostics, Inc. The company develops and distributes autoimmune disease diagnostics and reagents to labs worldwide. We offer laboratory testing of autoimmune diseases for the US healthcare market. Our contract research organization supports clinical research trials for pharmaceutical and biotech clients. Our assay development led to the first immunofluorescence assay for diagnosing celiac disease and the first Western blot assay for autoimmune hearing loss. Our new line of enhanced ELISA assays provides standardized calibration systems, an industry first. We are continually expanding our product offering.